Comparison
5p Partial Monosomy Syndrome C0010314 vs 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
Clinical comparison between 5P Partial Monosomy Syndrome and 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial for differential diagnosis and treatment planning.
5p Partial Monosomy Syndrome C0010314
Also called Cri-du-chat syndrome, caused by a deletion on chromosome 5. Features include a high-pitched cry, developmental delay, and intellectual disability.
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
A partial form of enzyme deficiency affecting hormone production. Symptoms vary but may include hormonal imbalances and elevated blood pressure. Treatment usually involves hormone replacement and regular medical follow-up.
6 comparison axes
Onset
5p Partial Monosomy Syndrome C0010314
0-0
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
Variable
Onset patterns differ
Severity
5p Partial Monosomy Syndrome C0010314
severe
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
severe
Different severity levels
Chronic
5p Partial Monosomy Syndrome C0010314
Chronic
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
Chronic
Differing course
Communicable
5p Partial Monosomy Syndrome C0010314
No
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
No
Different transmission
Body System
5p Partial Monosomy Syndrome C0010314
congenital
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
endocrine
Same/different system
Category
5p Partial Monosomy Syndrome C0010314
genetic
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
endocrine
Different category
Bottom line
5p-partial-monosomy-syndrome-C0010314 and 17-alpha-hydroxylase-17-20-lyase-deficiency-combined-partial-C4017190 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 5p Partial Monosomy Syndrome C0010314 | 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190 | Discriminating power |
|---|---|---|---|
| Early cry and development | A high-pitched cry, developmental delay, and intellectual disability may occur. | These neurodevelopmental features are not the defining presentation. | High |
| Blood pressure and hormones | Hypertension and steroid imbalance are not characteristic in the source. | Partial deficiency may cause hormone imbalance and elevated blood pressure. | High |
| Primary disease category | Congenital genetic condition caused by deletion on chromosome 5. | Endocrine disorder affecting adrenal and sex-hormone production. | High |
When to favor each condition
Choose 5p Partial Monosomy Syndrome C0010314 when
Infant has a characteristic cry and developmental concerns
This pattern aligns better with 5p deletion than an enzyme defect.
High
A chromosomal abnormality is suspected
Genetic testing can support or exclude a chromosome 5 deletion.
High
No primary endocrine features are evident
Lack of hormone-related findings makes the enzyme diagnosis less likely.
Moderate
Choose 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190 when
Hypertension accompanies suspected steroid imbalance
This pattern fits the partial enzyme deficiency better.
Moderate
Puberty or sex-hormone findings are abnormal
The deficiency can variably affect adrenal and gonadal hormones.
Moderate
Chromosome 5 testing does not show deletion
A negative genetic result shifts attention toward endocrine evaluation.
Moderate
How key tests differ
| Test | 5p Partial Monosomy Syndrome C0010314 | 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190 | Interpretation |
|---|---|---|---|
| Karyotype or chromosomal microarray | May detect a deletion involving chromosome 5p. | Not expected to identify this enzyme deficiency. | A detected deletion supports the chromosomal diagnosis but needs laboratory confirmation. |
| Steroid hormone profile | No characteristic steroid pattern is established here. | May show altered hormone production; exact cutoffs are not supplied. | Abnormal results are not a diagnosis by themselves and need clinician review. |
| Blood pressure assessment | Hypertension is not a defining feature. | Elevated blood pressure may be present. | Hypertension supports endocrine assessment but does not confirm the deficiency. |
Prognosis comparison
5p Partial Monosomy Syndrome C0010314
- Outcome
- Lifelong developmental effects are possible, but outcomes vary.
- Factors
- Deletion extent, associated findings, therapy, and available support.
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
- Outcome
- Hormone care and blood-pressure management may help, but course varies.
- Factors
- Degree of deficiency, hormone balance, blood pressure, and follow-up.
Time frame: Lifelong, with onset at birth for the left and variable for the right.
The sources do not establish mortality or one predictable outcome.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental disability | Developmental delay and intellectual disability may occur. Not described as the primary complication. Support and therapy needs should be individualized. |
| Blood-pressure-related risk | A defining cardiovascular complication is not established here. Elevated blood pressure may create cardiovascular concern. Exact risk and targets are not supplied and require clinical monitoring. |
| Pubertal or reproductive effects | Not a defining feature in the supplied description. Hormone imbalance may variably affect puberty or fertility. Partial deficiency means presentation and severity are not uniform. |
Patient education highlights
- HighDifferent diagnoses
A chromosome deletion and an enzyme deficiency require different specialist testing.
- HighOngoing care
Both can be chronic; follow-up and supportive care should be individualized.
- MediumChanges to report
Report developmental concerns, unusual blood pressure, or puberty changes promptly.